The Prevalence and Importance of Frailty in Heart Failure with Reduced Ejection Fraction – An Analysis of PARADIGM-HF and ATMOSPHERE
Pooja Dewan(British Heart Foundation), John J.V. McMurray(University of Glasgow), Lars Køber(University of Copenhagen), Milton Packer(Baylor University Medical Center), Michael R. Zile(Medical University of South Carolina), Scott D. Solomon(Brigham and Women's Hospital), Alice M. Jackson(University of Glasgow), William T. Abraham(The Ohio State University), Karl Swedberg(Brigham and Women's Hospital), João Pedro Ferreira(Inserm), Akshay S. Desai(Brigham and Women's Hospital), Li Shen(South China Agricultural University), Kenneth Dickstein, Mark C. Petrie(British Heart Foundation), Jean L. Rouleau(Montreal Heart Institute), Pardeep S. Jhund(Copenhagen University Hospital)
Cited by 141
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
|Journal of the American Society of Echocardiography|2005|11.3k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k